clorazepate dipotassium has been researched along with Neurotic Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobus, A; Rajewski, A; Rybakowski, J; Strzyzewski, W | 1 |
1 trial(s) available for clorazepate dipotassium and Neurotic Disorders
| Article | Year |
|---|---|
[Clinical effectiveness of clorazepate dipotassium (Tranxilium 20), used in a single daily dose, in neurotic disorders].
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Clorazepate Dipotassium; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurotic Disorders; Placebos | 1983 |